Analysts Issue Conflicting Price Targets for Nuvation Bio
JonesTrading raised Nuvation Bio's price target to $12, citing optimism for Safusidenib data, while H.C. Wainwright lowered its target to $17 due to sales concerns.
Topic
Latest reporting and analysis tagged with Nuvation Bio.
JonesTrading raised Nuvation Bio's price target to $12, citing optimism for Safusidenib data, while H.C. Wainwright lowered its target to $17 due to sales concerns.